Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases

C Raptis; D Andrey; C Berger; A Finckh; P Lescuyer; A Ciurea; T Maletic; C Polysopoulos; M Riek; A Scherer; K Lauper; B Moeller; J Safford; S Schweizer; I von Loga; N Vuilleumier; A Rubbert-Roth

Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases

C Raptis, D Andrey, C Berger, A Finckh, P Lescuyer, A Ciurea, T Maletic, C Polysopoulos, M Riek, A Scherer, K Lauper, B Moeller, J Safford, S Schweizer, I von Loga, N Vuilleumier, A Rubbert-Roth

Division of Musculoskeletal & Dermatological Sciences

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	4083-4086
Number of pages	4
Journal	Arthritis & Rheumatology (Hoboken)
Volume	73
Publication status	Published - Sept 2021

Cite this

Raptis, C., Andrey, D., Berger, C., Finckh, A., Lescuyer, P., Ciurea, A., Maletic, T., Polysopoulos, C., Riek, M., Scherer, A., Lauper, K., Moeller, B., Safford, J., Schweizer, S., von Loga, I., Vuilleumier, N., & Rubbert-Roth, A. (2021). Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases. Arthritis & Rheumatology (Hoboken), 73, 4083-4086.

@article{98abe7c9af7740ceab02c189e30d9f54,

title = "Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases",

author = "C Raptis and D Andrey and C Berger and A Finckh and P Lescuyer and A Ciurea and T Maletic and C Polysopoulos and M Riek and A Scherer and K Lauper and B Moeller and J Safford and S Schweizer and {von Loga}, I and N Vuilleumier and A Rubbert-Roth",

year = "2021",

month = sep,

language = "English",

volume = "73",

pages = "4083--4086",

journal = "Arthritis & Rheumatology (Hoboken)",

issn = "2326-5191",

publisher = "John Wiley & Sons Ltd",

}

Raptis, C, Andrey, D, Berger, C, Finckh, A, Lescuyer, P, Ciurea, A, Maletic, T, Polysopoulos, C, Riek, M, Scherer, A, Lauper, K, Moeller, B, Safford, J, Schweizer, S, von Loga, I, Vuilleumier, N & Rubbert-Roth, A 2021, 'Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases', Arthritis & Rheumatology (Hoboken), vol. 73, pp. 4083-4086.

TY - JOUR

T1 - Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases

AU - Raptis, C

AU - Andrey, D

AU - Berger, C

AU - Finckh, A

AU - Lescuyer, P

AU - Ciurea, A

AU - Maletic, T

AU - Polysopoulos, C

AU - Riek, M

AU - Scherer, A

AU - Lauper, K

AU - Moeller, B

AU - Safford, J

AU - Schweizer, S

AU - von Loga, I

AU - Vuilleumier, N

AU - Rubbert-Roth, A

PY - 2021/9

Y1 - 2021/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000744545207261&DestLinkType=FullRecord&DestApp=WOS

M3 - Meeting Abstract

SN - 2326-5191

VL - 73

SP - 4083

EP - 4086

JO - Arthritis & Rheumatology (Hoboken)

JF - Arthritis & Rheumatology (Hoboken)

ER -

Immunogenicity of mRNA COVID-19 Vaccines at 4 and 12 Weeks Post Full Vaccination in Patients with Inflammatory Rheumatic Diseases

Other files and links

Cite this